Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Stephen Chrzanowski, MD, PhD
Aravindhan Veerapandiyan, MD
Advances in Managing Neuropsychiatric Symptoms of Alzheimer’s Disease: From Early Detection to Emerging Therapies
Marwan Sabbagh, MD, FAAN
Christoph U. Correll, MD
Alireza Atri, MD, PhD
From Resistance to Response: Evolving Strategies in MDD Management
Joseph F. Goldberg, MD
Treatment of a Broader Population of Patients With DMD
Crystal Proud, MD
Erika Finanger, MD, MS
Recognizing Early Signs of LGMD2I/R9
John Vissing, MD, DMSci
Advancing Care: Clinical Innovations on the Horizon
Establishing Our Foundation of LGMD2I/R9
Conrad Weihl, MD, PhD
Integrating Perspectives: The Value of Patient and Caregiver Input
Optimizing Patient Management Strategies
The Role of Multidisciplinary Care in LGMD2I/R9
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
James R. Bateman, MD, MPH
B. Joy Snider, MD, PhD
Charles P. Vega, MD
Clinical Conundrums in ARIA: Triage and Imaging in the Emergency Setting for Patients Prescribed Anti-Aβ mAbs
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Jerome A. Barakos, MD
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Clinical Conundrums in ARIA: How to Manage Severe ARIA
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.